# Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

> **NCT03368677** · — · ACTIVE_NOT_RECRUITING · sponsor: **Turku University Hospital** · enrollment: 26 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03368677
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03368677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03368677, "Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03368677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*